Efficacy of ticagrelor monotherapy compared with ticagrelor plus aspirin in high-risk patients undergoing PCI

Efficacy of ticagrelor monotherapy compared with ticagrelor plus aspirin in high-risk patients undergoing PCI

2020.03.30

In high-risk patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stents, ticagrelor monotherapy provides similar antithrombotic benefits as ticagrelor plus acetylsalicylic...

Swedish cohort shows gender differences in relation to hyperuricaemia and subclinical atherosclerosis

Swedish cohort shows gender differences in relation to hyperuricaemia and subclinical atherosclerosis

2020.03.23

Hyperuricaemia is closely associated with cardiovascular disease (CVD), but whether this association is independent of traditional cardiovascular risk factors (CVRFs), and whether it is gender-...

Coronary artery calcification and inflammation impact adverse cardiovascular events post-PCI

Coronary artery calcification and inflammation impact adverse cardiovascular events post-PCI

2020.03.16

Patients with both coronary artery calcification (CAC) and systemic inflammation have an increased risk of major adverse cardiovascular events (MACE) after percutaneous coronary intervention (PCI),...

Combining novel biomarkers improves risk prediction of cardiovascular mortality in STEMI patients

Combining novel biomarkers improves risk prediction of cardiovascular mortality in STEMI patients

2020.03.09

In patients with ST-elevation myocardial infarction (STEMI), novel biomarkers ST2 and Pentraxin-3 (Ptx-3) are associated with the incidence of cardiovascular mortality (CV-mortality), in addition to...

Near-infrared spectroscopy intravascular ultrasound imaging shows promise as diagnostic tool for high-risk ACS patients

Near-infrared spectroscopy intravascular ultrasound imaging shows promise as diagnostic tool for high-risk ACS patients

2020.03.02

In a prospective cohort study of patients from 44 medical centres in Italy, Latvia, Netherlands, Slovakia, UK and the USA, near-infrared spectroscopy (NIRS) intravascular ultrasound imaging was shown...

Experimental treatment with ticagrelor monotherapy benefits non-obese ACS patients

Experimental treatment with ticagrelor monotherapy benefits non-obese ACS patients

2020.02.24

A subgroup analysis of a large, multicentre, randomized controlled trial has demonstrated a beneficial effect of ticagrelor monotherapy in non-obese acute coronary syndrome (ACS) patients.The GLOBAL...

Chinese researchers predict the risk of new-onset ACS in patients with diabetes

Chinese researchers predict the risk of new-onset ACS in patients with diabetes

2020.02.21

Researchers have developed a potent risk predictive model to predict the probability of new-onset acute coronary syndrome (ACS) in patients with type 2 diabetes mellitus (T2DM), using data from the...

Octogenarians with ACS expect their treatment to result in increased wellbeing and fewer symptoms

Octogenarians with ACS expect their treatment to result in increased wellbeing and fewer symptoms

2020.02.17

Researchers have collected valuable insights into the preferences and expectations of elderly people for acute coronary syndrome (ACS) treatment, helping to add to the evidence about whether this...

Smoking impacts mortality post-PCI

Smoking impacts mortality post-PCI

2020.02.14

Current smokers undergo percutaneous coronary intervention (PCI) at a younger age and have higher short-term mortality compared with ex-smokers and never smokers, according to results from a...

Blood platelet count at hospital admission impacts long-term mortality in ACS patients

Blood platelet count at hospital admission impacts long-term mortality in ACS patients

2020.02.10

Patients with acute coronary syndrome (ACS) and who have thrombocytopenia or thrombocytosis at hospital admission have almost twice the mortality rate at 5 years compared with those with normal blood...